Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-010611)

Filing Details

Accession Number:: 0001209191-23-010611
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2023-02-17 16:23:48
Reporting Period:: 2022-12-15

Accepted Time:: 2023-02-17 16:23:48
Original Submission Date:: 2022-12-16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1796280	Oric Pharmaceuticals Inc.	ORIC	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1695028	Dominic Piscitelli	C/O Oric Pharmaceuticals, Inc. 240 E. Grand Ave., 2Nd Floor South San Francisco CA 94080	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-12-15	2,227	$3.08	67,285	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This amendment is filed to correct the number of shares sold, and the price per share at which the shares were sold, to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person.